Effectiveness, toxicity and treatment adjustments of lenvatinib plus pembrolizumab in advanced renal cell carcinoma: a multicenter real-world analysis
乐伐替尼联合帕博利珠单抗治疗晚期肾细胞癌的疗效、毒性和治疗调整:一项多中心真实世界分析
期刊:
影响因子:
doi:10.1016/j.esmorw.2025.100142
Stelmach, R; Erdmann, S; Schlack, K; Muehle, C; Darr, C; Neuberger, S; Reichert, M; Flegar, L; Egenolf, T; Rehlinghaus, M; Zengerling, F; Casuscelli, J; Cox, A; Vallet, S; Nestler, T; Brehmer, B; Ivanyi, P; Paffenholz, P; Neuberger, M; Jäger, D; Grünwald, V; Zschäbitz, S